Burke Ashley A, Severson Elizabeth S, Mool Shreya, Solares Bucaro Maria J, Greenaway Frederick T, Jakobsche Charles E
a Carlson School of Chemistry and Biochemistry, Clark University , Worcester , MA , USA.
J Enzyme Inhib Med Chem. 2017 Dec;32(1):496-503. doi: 10.1080/14756366.2016.1265518.
Lysyl oxidase has emerged as an important enzyme in cancer metastasis. Its activity has been reported to become upregulated in several types of cancer, and blocking its activity has been shown to limit the metastatic potential of various cancers. The small-molecules phenylhydrazine and β-aminopropionitrile are known to inhibit lysyl oxidase; however, issues of stability, toxicity, and poorly defined mechanisms limit their potential use in medical applications. The experiments presented herein evaluate three other families of hydrazine-derived compounds - hydrazides, alkyl hydrazines, and semicarbazides - as irreversible inhibitors of lysyl oxidase including determining the kinetic parameters and comparing the inhibition selectivities for lysyl oxidase against the topaquinone-containing diamine oxidase from lentil seedlings. The results suggest that the hydrazide group may be a useful core functionality that can be developed into potent and selective inhibitors of lysyl oxidase and eventually find application in cancer metastasis research.
赖氨酰氧化酶已成为癌症转移中的一种重要酶。据报道,其活性在几种类型的癌症中上调,并且阻断其活性已显示出可限制各种癌症的转移潜能。已知小分子苯肼和β-氨基丙腈可抑制赖氨酰氧化酶;然而,稳定性、毒性和机制不明确等问题限制了它们在医学应用中的潜在用途。本文介绍的实验评估了其他三类肼衍生化合物——酰肼、烷基肼和氨基脲——作为赖氨酰氧化酶的不可逆抑制剂,包括确定动力学参数以及比较赖氨酰氧化酶对来自小扁豆幼苗的含对苯醌二胺氧化酶的抑制选择性。结果表明,酰肼基团可能是一种有用的核心官能团,可开发成强效且选择性的赖氨酰氧化酶抑制剂,并最终在癌症转移研究中得到应用。